BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12604053)

  • 1. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
    Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
    J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-mediated DNA vaccination: the effect of vesicle composition.
    Perrie Y; Frederik PM; Gregoriadis G
    Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-mediated DNA immunisation via the subcutaneous route.
    Perrie Y; McNeil S; Vangala A
    J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-entrapped plasmid DNA: characterisation studies.
    Perrie Y; Gregoriadis G
    Biochim Biophys Acta; 2000 Jul; 1475(2):125-32. PubMed ID: 10832026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route.
    Perrie Y; Barralet JE; McNeil S; Vangala A
    Int J Pharm; 2004 Oct; 284(1-2):31-41. PubMed ID: 15454294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered via Lipodine liposomes.
    Bacon A; Caparrós-Wanderley W; Zadi B; Gregoriadis G
    J Liposome Res; 2002; 12(1-2):173-83. PubMed ID: 12604052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.
    Vangala A; Bramwell VW; McNeil S; Christensen D; Agger EM; Perrie Y
    J Control Release; 2007 May; 119(1):102-10. PubMed ID: 17331610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.
    Zhao DD; Watarai S; Lee JT; Kouchi S; Ohmori H; Yasuda T
    Acta Med Okayama; 1997 Jun; 51(3):149-54. PubMed ID: 9227794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-mediated DNA vaccination.
    Gregoriadis G; Saffie R; de Souza JB
    FEBS Lett; 1997 Feb; 402(2-3):107-10. PubMed ID: 9037176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the efficacy of liposomes in comparison to new and established adjuvants in potentiating the antibody response against hepatitis B virus surface antigen.
    Tan L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):83-7. PubMed ID: 1807265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes as immunological adjuvants: antigen incorporation studies.
    Gregoriadis G; Davis D; Davies A
    Vaccine; 1987 Jun; 5(2):145-51. PubMed ID: 3604394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel positively-charged lipid 1,2-bis(hexadecylcycloxy)-3-trimethyl aminopropane (BisHOP) enhances the adjuvant effect of liposomes on encapsulated tetanus toxoid.
    Tan L; Gregoriadis G
    Asian Pac J Allergy Immunol; 1991 Jun; 9(1):21-4. PubMed ID: 1776976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadjuvant action of liposomes: comparison with other adjuvants.
    Gregoriadis G; Panagiotidi C
    Immunol Lett; 1989 Feb; 20(3):237-40. PubMed ID: 2714847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
    Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization--extrusion technique.
    Pupo E; Padrón A; Santana E; Sotolongo J; Quintana D; Dueñas S; Duarte C; de la Rosa MC; Hardy E
    J Control Release; 2005 May; 104(2):379-96. PubMed ID: 15907587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for liposomes in genetic vaccination.
    Gregoriadis G; Bacon A; Caparros-Wanderley W; McCormack B
    Vaccine; 2002 Dec; 20 Suppl 5():B1-9. PubMed ID: 12477411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of microfluidization of protein-coated liposomes on protein distribution on the surface of generated small vesicles.
    Skalko N; Bouwstra J; Spies F; Gregoriadis G
    Biochim Biophys Acta; 1996 Jun; 1301(3):249-54. PubMed ID: 8664336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.